A $16K Humanoid Completed a Gallbladder Removal in a Pig — But a Human Drove Every Move
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice. The 30-second version What. A UC San Diego team (Yip lab) mounted wristed laparoscopic instruments on a low-cost commercial humanoid (Unitree G1) and ran a three-stage study — benchtop characterization, dry-lab user study,…
Blocking the Clot Is Not Protecting the Brain: An Unpeer-Reviewed UK Biobank Preprint on Atrial Fibrillation and Brain Health (n=502,099)
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice, and not medical advice. The paper discussed below is a medRxiv preprint (v1, posted 2026-08-12) that has not yet been peer-reviewed. It is an observational cohort analysis with Mendelian randomization as a secondary…
Mechanism-Encoded Prediction of Prime Editing: What OptiPrime’s Ablations Actually Prove, and What Remains Unconfirmed
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice. The Nature Biotechnology version of the paper discussed here is paywalled and was not accessed by this outlet. Everything below marked “confirmed” was verified directly against the bioRxiv preprint (submitted 2026-02-20), which the…
Is Retrieval All You Need? Depends How You Score It — An In Silico Preprint Recalibrates Protein-Generator Novelty Claims
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice. The paper discussed here is an unpeer-reviewed arXiv preprint (submitted 2026-08-11), and every comparison in it — including the one summarized below — is an in silico structural alignment and scoring exercise. No…
A genome language model designed working bacteriophages — and a second paper the same week shows the capability is not uniform
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice, not medical advice. The 30-second version What. A paper in Science (6 August 2026) reports the first generative design of complete bacteriophage genomes using genome language models. Working from the phage ΦX174 as…
Three levers on fault-tolerance overhead — and why they sit on three different evidence tiers
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice. The 30-second version What. Fault-tolerant quantum computing has one dominant cost: the number of physical qubits and operations needed per useful logical qubit. Four results from 2026 push on that cost from three…
A million exomes point at FNIP1 — and at how narrow the window for hitting it may be
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice, not medical advice. The 30-second version What. An exome-sequencing analysis of 1,032,116 people across America, Europe and Asia tested rare protein-coding variants against the triglyceride-to-HDL ratio, used as a biomarker of energy state…
Finerenone across CKM stages — the relative effect is flat, the absolute benefit is not, and the new endpoint moves its own goalposts
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice, not medical advice. The 30-second version What. A post hoc analysis of 12,990 people with type 2 diabetes and chronic kidney disease from two phase 3 trials, pooled and then re-classified using the…
Retatrutide in early type 2 diabetes — the glucose axis converges, the weight axis does not
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice, not medical advice. The 30-second version What. In 537 adults with early type 2 diabetes inadequately controlled on diet and exercise (mean duration 2.5 years, HbA1c 7.9%, BMI 35.8), 40 weeks of once-weekly…
MASLD non-invasive tests — fibrosis staging clears the bar, the MASH treatment gate does not
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice, not medical advice. The 30-second version What. In a prospective, multicenter cohort with centrally read liver biopsy as the reference standard (LITMUS Imaging Study, N = 357, Nature Medicine, published online July 24,…
Something went wrong. Please refresh the page and/or try again.
Follow My Blog
Get new content delivered directly to your inbox.
Uthando Nethemba 